Andrew S Boyer
Executive Vice President · 4 filings · Latest: Sep 1, 2026
Amneal Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMRX | Andrew S Boyer | Executive Vice President | Mar 4, 2026 | Option Exercise | — | 38,195 | — | 445,208 | |
AMRX | Andrew S Boyer | Executive Vice President | Mar 3, 2026 | Option Exercise | — | 510,758 | — | 606,188 | |
AMRX | BOYER ANDREW S | — | Aug 20, 2025 | Proposed Sale | $9.36 | 175,000 | $1.6M | — | |
AMRX | BOYER ANDREW S | — | Aug 20, 2025 | Proposed Sale | $9.30 | 104,244 | $969.5K | — | |
AMRX | BOYER ANDREW S | — | Aug 12, 2025 | Proposed Sale | $9.09 | 33,436 | $304.1K | — | |
AMRX | BOYER ANDREW S | — | Mar 5, 2025 | Proposed Sale | $8.87 | 125,000 | $1.1M | — |